Optimizing Decellularized Human Umbilical Vein as a Scaffold for Vascular Tissue Engineering.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Cardiovascular Research

Background:

• Increasing cardiovascular disease necessitates advanced vascular graft solutions.
• Decellularized human umbilical vein (HUV) presents a promising biocompatible scaffold.
• Extracellular matrix (ECM) preservation is key for graft function.

Purpose of the Study:

• To assess a sodium dodecyl sulfate (SDS)-based decellularization protocol for HUVs.
• To optimize HUV preparation for subsequent stem cell seeding.
• To evaluate the efficacy of SDS concentration and duration on HUV decellularization.

Main Methods:

• Human umbilical veins (HUVs) underwent decellularization using varying SDS concentrations (0.5%, 1%) and durations (6, 12, 24 hours).
• Scaffolds were analyzed for DNA content, cell viability (MTT assay), collagen/elastin retention, and histological changes.
• Freeze-drying and gamma-sterilization were employed post-decellularization.

Main Results:

• The optimal protocol (0.5% SDS, 6 hours) significantly reduced cellularity and DNA content.
• Cell viability remained high (87.05 ± 17.14%), comparable to controls (84.79 ± 14.3%).
• Collagen and elastin retention were preserved, indicating intact ECM structure.

Conclusions:

• The 0.5% SDS, 6-hour protocol is effective for HUV decellularization.
• This method successfully removes cellular components while maintaining ECM integrity.
• The prepared HUV scaffolds are suitable for vascular tissue engineering applications.